Free Newsletter
Register for our Free Newsletters
Advanced Composites
Amorphous Metal Structures
Analysis and Simulation
Asbestos and Substitutes
Associations, Research Organisations and Universities
Automation Equipment
Building Materials
Bulk Handling and Storage
CFCs and Substitutes
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Manufacturing Zone
Pro Security Zone
Web Lec
Pro Engineering Zone

Rare form of obsessive compulsive disorder associated with gene mutation

Yale University : 28 October, 2003  (New Product)
A rare form of obsessive-compulsive disorder is associated with an uncommon gene mutation, according to Yale and National Institutes of Mental Health researchers.
The findings are the strongest evidence to date that neuropsychiatric disease can result from mutations in neuronal proteins.

Dennis Murphy and colleagues at NIMH, Gary Rudnick, professor of pharmacology at Yale School of Medicine, and Fusun Kilic, also of Yale, conducted the research. The studies appeared in Molecular Psychiatry October 23 and in Molecular Pharmacology in August.

'There are not a lot of established connections between genes and behavior, especially abnormal behavior,' Rudnick said. 'Our finding focuses on the serotonin transporter for mood and behavior and ties it to a specific behavioral disorder. This transporter is a target for cocaine, amphetamines and ecstasy, in addition to anti-depressant drugs.'

Serotonin is found throughout the body, particularly in the brain, where it acts as a neurotransmitter. It is released from one nerve cell into a synapse, or space, between nerves, then interacts with receptors on the surface of another cell to transmit the signal. When serotonin is released, the human serotonin transporter, hSERT, is responsible for removing serotonin from the synapse by transporting it back into the cell. Some anti-depressant drugs, used to treat neuropsychiatric disorders such as affective disorder, anxiety disorders, OCD and autism, inhibit hSERT re-uptake of serotonin in the brain.

Murphy's group at NIH discovered that a small group of patients with OCD carried a mutation in the serotonin transporter gene. DNA samples taken from two unrelated families with OCD found half had mutations, and did not respond to drugs designed to inhibit hSERT activity.

Rudnick's group measured the activity of the mutant protein and found that the mutant protein was better than the normal protein at transporting serotonin. Usually mutations interfere with function. They demonstrated that this mutation increased the transport activity of the neuronal protein due to a defect in the regulation of hSERT.

Rudnick said following up on these findings might lead to a better understanding of the way most OCD cases develop and how medications affecting hSERT might be used in their treatment. He said it also might offer insight into how mood altering drugs work.
Bookmark and Share
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
   © 2012
Netgains Logo